Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Respiratory Medicine and Research is Scopus-indexed (Q3, CiteScore 3.2), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Elsevier Masson s.r.l..
Checked against the index lists dated .
ISSN 2590-0412Verify ISSN ↗
Publisher: Elsevier Masson s.r.l.
Cost to publish: About US$1,670 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pulmonary and Respiratory Medicine | 84 / 165 | 49th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2019–present, best quartile Q3, CiteScore 3.2.
Respiratory Medicine and Research is Q3 in Pulmonary and Respiratory Medicine (rank 84 of 165), by CiteScore 2025.
Respiratory Medicine and Research is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.2, which places it in quartile Q3 at the 49th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.624, quartile Q2, with an H-index of 22.
The publisher lists an article processing charge of about US$1,670 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Respiratory Medicine and Research is published by Elsevier Masson s.r.l. Its ISSN is 2590-0412.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Respiratory Medicine and Research has an h-index of 21 and a 2-year mean of 0.81 citations per paper (OpenAlex). Its Scopus CiteScore is 3.2, quartile Q3. On 2-year citations it ranks #103 of 160 Scopus journals in Pulmonary and Respiratory Medicine.
Respiratory Medicine and Research published 89 papers in 2025; its busiest recent year was 2023 with 92. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2025–2026), authors are most often from France (56.4%), United States (6%) and United Kingdom (5.2%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.